Detalhe da pesquisa
1.
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
Breast Cancer Res Treat
; 161(3): 575-586, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28008555
2.
Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Ann Surg Oncol
; 22(10): 3282-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26219241
3.
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
JAMA Oncol
; 5(1): 51-57, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128536
4.
Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.
J Natl Cancer Inst
; 110(8): 863-870, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529297
5.
Quality of Clinician-Reported Cancer History When Ordering Genetic Testing.
JCO Clin Cancer Inform
; 2: 1-11, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30652589
6.
Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
J Clin Oncol
; 35(22): 2568-2575, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514183
7.
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA Oncol
; 3(9): 1190-1196, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28418444
8.
Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.
Cancer Genet
; 209(9): 403-407, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27751358
9.
Tracking hypoxic signaling in encapsulated stem cells.
Tissue Eng Part C Methods
; 18(7): 557-65, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22250882